Immunohematology Market, By Type (Analyzers and Reagents), By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Immunohematology Market size was valued at US$ 2,609.43 Million in 2024, expanding at a CAGR of 7.82% from 2025 to 2032.
Immunohematology, commonly known as blood banking or transfusion medicine, is a specialized branch of hematology and immunology that focuses on the study of blood antigens and antibodies. This field plays a vital role in healthcare, ensuring the safe identification and compatibility of blood for transfusions while also addressing immune-related blood disorders. The core of immunohematology revolves around detecting, characterizing, and understanding the clinical implications of blood group antigens and their corresponding antibodies. A fundamental aspect of immunohematology is the ABO and Rh blood group systems, which are crucial in determining blood compatibility. Essential diagnostic tests in this field include cross-matching, irregular antibody screening, and antigen detection to prevent adverse transfusion reactions and complications during pregnancy, such as hemolytic disease of the fetus and newborn. The significance of immunohematology extends across various medical applications, including trauma care, surgical procedures, anemia management, and chronic disease treatment. Modern medicine relies heavily on this discipline, as the safe use of blood and its components is indispensable for saving lives and improving patient outcomes.
Immunohematology Market- Market Dynamics
The immunohematology market is experiencing significant growth, driven by the rising prevalence of hematological disorders and chronic diseases. According to the World Health Organization (WHO), anemia affects approximately 1.62 billion people globally, underscoring the critical need for advanced blood testing and transfusion services. Additionally, the increasing number of surgical procedures worldwide further fuels the demand for blood products and immunohematology diagnostics. Government initiatives promoting blood donation and awareness campaigns have enhanced the availability of blood supplies, contributing to market expansion.
Technological advancements, such as next-generation sequencing and polymerase chain reaction (PCR), have improved the accuracy and reliability of immunohematology diagnostics, leading to wider adoption in clinical settings. Emerging markets present substantial growth opportunities as developing countries invest in healthcare infrastructure to enhance diagnostics and blood transfusion services. The growing trend of personalized medicine and patient-specific blood management strategies is also creating demand for specialized immunohematology products and services. Furthermore, public-private collaborations aimed at improving blood donation awareness and ensuring higher safety standards are expected to support market growth. However, challenges such as the high cost of advanced diagnostic equipment and the need for highly skilled personnel to operate complex instruments may hinder market expansion. Additionally, stringent regulatory requirements for blood products and diagnostic devices can delay product approvals, potentially affecting the timely availability of innovative solutions in the market.
Immunohematology Market- Segmentation Analysis:
The Global Immunohematology Market is segmented on the basis of Type, Application, End User, and Region.
The immunohematology market is segmented by Type into Analyzers and Reagents. The Reagents segment dominates the market, as they are essential for blood grouping, cross-matching, and screening processes. The growing incidence of hematological diseases and the increasing frequency of blood transfusions have heightened the reliance on high-accuracy blood banking reagent kits. These reagents play a crucial role in hospitals, blood banks, and diagnostic laboratories, ensuring compatibility in blood transfusions and the management of hemolytic diseases. The demand for reliable reagents is further reinforced by stringent regulatory standards for transfusion safety, such as those set by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
The Analyzers segment is expected to witness the fastest growth during the forecast period, driven by the increasing demand for automated and semi-automated analyzers that offer enhanced precision, faster turnaround times, and improved workflow efficiency. The global shift toward automation in laboratory settings is one of the most significant growth drivers for this segment. Automated analyzers help reduce human errors, improve test standardization, and enhance laboratory productivity. Governments worldwide are promoting automation in blood testing to improve transfusion safety and efficiency. For instance, the World Health Organization (WHO) has urged nations to modernize blood transfusion services through automated technologies to enhance the quality and reliability of blood testing procedures.
By End Use, the immunohematology market is segmented into Blood Banks, Hospitals, Diagnostic & Reference Laboratories, and Academic & Research Institutes. Hospitals hold the largest market share, as they are the primary centers for patient care, where blood typing, cross-matching, and transfusion services are frequently required during surgical procedures, trauma cases, and critical care treatments. Hospitals are equipped with advanced diagnostic facilities and skilled personnel, ensuring the accurate processing of immunohematology tests. Government healthcare initiatives supporting better transfusion management and patient safety further drive hospital demand for immunohematology solutions. For example, the U.S. Health Resources & Services Administration (HRSA) actively supports hospitals in improving blood transfusion safety through funding and regulatory oversight.
The Blood Banks segment is expected to grow at the highest CAGR, fueled by increasing awareness campaigns and voluntary blood donation programs. The expansion of blood banks and collection centers worldwide is further boosting demand. Many governments and organizations, including the Red Cross and WHO, are implementing programs to increase blood donation rates and improve storage facilities. In developing countries, investments in blood bank infrastructure are significantly improving access to safe and sufficient blood supplies. Additionally, the adoption of advanced immunohematology technologies in blood banks to ensure infection-free and compatible blood transfusions is further accelerating market growth. The WHO’s Global Blood Safety Initiative aims to ensure that 100% of blood donations are screened with high-quality testing technologies, driving continuous upgrades in immunohematology testing systems across blood banks worldwide.
Immunohematology Market- Geographical Insights
North America leads the immunohematology market, driven by its advanced healthcare infrastructure and widespread adoption of cutting-edge medical technologies. The region\'s high demand for transfusion-related products and services is underscored by the United States, which transfuses approximately 14.6 million units of blood annually, according to the Centers for Disease Control and Prevention (CDC). The strong presence of well-established healthcare systems and continuous investments in medical advancements further solidify the dominance of the U.S. and Canada in this market.
Meanwhile, the Asia-Pacific region is expected to witness the fastest growth in the coming years. Rising healthcare expenditures, increasing awareness about blood donation, and the growing prevalence of blood-related disorders are fueling market expansion. Countries such as India and China have significantly improved their healthcare infrastructure and blood transfusion services, with the World Health Organization (WHO) noting steady progress in these areas. As a result, nations like China, India, and Japan are emerging as key contributors to the region’s growing immunohematology market, with continued advancements expected to drive further growth.
Immunohematology Market- Competitive Landscape:
The global immunohematology market is highly competitive, with key players driving innovation and expanding their market presence. Leading companies such as Bio-Rad Laboratories, Inc., Immucor, Ortho Clinical Diagnostics, Grifols, and BD (Becton Dickinson) dominate the market due to their extensive product portfolios and strong distribution networks. These players focus on developing advanced immunohematology solutions, including automated analyzers, reagents, and molecular diagnostics, to improve diagnostic accuracy and efficiency. Strategic collaborations, mergers, and acquisitions are common strategies used to expand product offerings and penetrate emerging markets. Companies are actively targeting growing markets in Asia-Pacific and Latin America by partnering with healthcare institutions and blood banks. Additionally, significant investments in research and development are driving the introduction of next-generation immunohematology technologies, shaping the competitive landscape. This dynamic environment is expected to spur further advancements in the immunohematology sector.
Recent Developments:
• April 2024: Grifols launched the Erytra Eflexis automated blood-typing technology in China following regulatory approval. The system enhances efficiency in blood banks by automating blood-typing processes.
• May 2023: Bio-Rad Laboratories, Inc. introduced the IH-500™ NEXT System, an advanced automated ID-Card system designed to improve blood type testing sensitivity and antibody screening.
• November 2023: Versiti acquired Pearl Pathways, an Indianapolis-based blood management software company, to enhance its digital capabilities and optimize the blood supply chain.
• July 2023: QuidelOrtho partnered with BYG4lab to strengthen its informatics offerings, focusing on developing new software solutions for blood banks and transfusion centers.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOHEMATOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Bio-Rad Laboratories, Inc.
Ø Immucor
Ø Ortho Clinical Diagnostics
Ø Grifols
Ø BD (Becton Dickinson)
Ø Hologic, Inc.
Ø Siemens Healthineers
Ø ThermoFisher
Ø Abbott
Ø Beckman Coulter, Inc.
GLOBAL IMMUNOHEMATOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Analyzers
Ø Reagents
GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Antibody Screening
Ø Blood Typing
GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Ø Blood Banks
Ø Hospitals
Ø Diagnostic and Reference Laboratories
Ø Academic and Research Institutes
GLOBAL IMMUNOHEMATOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Immunohematology Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Immunohematology Market Snippet By Type
2.1.2. Immunohematology Market Snippet by Application
2.1.3. Immunohematology Market Snippet By End User
2.1.4. Immunohematology Market Snippet by Country
2.1.5. Immunohematology Market Snippet by Region
2.2. Competitive Insights
3. Immunohematology Key Market Trends
3.1. Immunohematology Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immunohematology Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immunohematology Market Opportunities
3.4. Immunohematology Market Future Trends
4. Immunohematology Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immunohematology Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Immunohematology Market Landscape
6.1. Immunohematology Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immunohematology Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Analyzers
7.1.3. Reagents
8. Immunohematology Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Antibody Screening
8.1.3. Blood Typing
9. Immunohematology Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Blood Banks
9.1.3. Hospitals
9.1.4. Diagnostic and Reference Laboratories
9.1.5. Academic and Research Institutes
10. Immunohematology Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Immunohematology Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Immunohematology Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Immunohematology Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Immunohematology Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Immunohematology Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Immunohematology Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Bio-Rad Laboratories, Inc.
11.2.2. Immucor
11.2.3. Ortho Clinical Diagnostics
11.2.4. Grifols
11.2.5. BD (Becton Dickinson)
11.2.6. Hologic, Inc.
11.2.7. Siemens Healthineers
11.2.8. ThermoFisher
11.2.9. Abbott
11.2.10. Beckman Coulter, Inc.
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
